Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Essential Therapeutics, Inc.”

7 pharma patents match "Essential Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Essential Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Essential Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 6723716

    7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof

    Essential Therapeutics, Inc. · Granted Apr 20, 2004 · Expires Apr 15, 2024

    expired

  2. US 6689782

    Fungal efflux pump inhibitors

    Essential Therapeutics, Inc. · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired

  3. US 6599893

    Cephalosporin antibiotics and prodrugs thereof

    Essential Therapeutics, Inc. · Granted Jul 29, 2003 · Expires Jul 24, 2023

    expired

  4. US 6596723

    Fungal efflux pump inhibitors

    Essential Therapeutics, Inc. · Granted Jul 22, 2003 · Expires Jul 17, 2023

    expired

  5. US 6495591

    Fungal efflux pump inhibitors

    Essential Therapeutics, Inc. · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  6. US 6482921

    Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use

    Essential Therapeutics, Inc. · Granted Nov 19, 2002 · Expires Nov 14, 2022

    expired

  7. US 6436980

    Peptidomimetic efflux pump inhibitors

    Essential Therapeutics, Inc. · Granted Aug 20, 2002 · Expires Aug 15, 2022

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.